Rachid Izzar - Feb 10, 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Global Product Strat.
Signature
/s/ Samuel Ntonme, attorney-in-fact for Rachid Izzar
Stock symbol
BIIB
Transactions as of
Feb 10, 2025
Transactions value $
-$63,430
Form type
4
Date filed
2/12/2025, 05:40 PM
Previous filing
Feb 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +1.52K +20.25% $0.00 9K Feb 10, 2025 Direct F1
transaction BIIB Common Stock Tax liability -$63.4K -445 -4.95% $142.54 8.55K Feb 10, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -1.52K -100% $0.00 0 Feb 10, 2025 Common Stock 1.52K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order.
F2 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.